75-Year-Old Survives Heart Attack After Swift Emergency Response in Vladivostok
75-Year-Old Survives Heart Attack After Swift Emergency Response in Vladivostok
75-Year-Old Survives Heart Attack After Swift Emergency Response in Vladivostok
A 75-year-old woman in Vladivostok survived a severe heart attack thanks to the rapid response of emergency teams. The incident began early on December 8, when she called for help after experiencing intense chest pain. The distress call came in at 9 a.m., with the patient reporting crushing pain behind her sternum that spread to her neck. Paramedics arrived quickly and conducted an on-site ECG, confirming an acute myocardial infarction. She was immediately transported to the regional vascular center at Primorsky Regional Clinical Hospital No. 1. There, a coordinated team of cardiac specialists performed emergency stenting to restore blood flow. The procedure succeeded, and her heart health began to stabilize. Doctors noted that the seamless teamwork between paramedics, emergency responders, and surgeons was crucial in saving her life. By the following day, she had been transferred to a general ward, where she was able to walk without assistance. The woman's recovery continues under medical supervision. Her case highlights the effectiveness of Vladivostok's emergency cardiac care system. No official figures for 2025's heart attack cases in Primorsky Krai have been released so far.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?